玉溪专业打胎手术医院(玉溪哪里做无痛人流比较好) (今日更新中)

BEIJING, March 14 (Xinhuanet) – "Angry Birds" game developers at Rovio have announced a funding of 42 million U.S. dollars to expand their "mean pigs, cranky birds" empire, according to foreign media report Sunday.The funding, announced Thursday, is the first venture-capital money Rovio has secured. Richard Wong with Accel Partners, who led the firm's investment in Rovio, hailed "Angry Birds" as "an incredible consumer franchise beyond just being a mobile game."With the newly raised funding, "Angry Birds" developers have made a strategic plan to achieve the brand growth of "Angry Birds."According to developer Peter "Mighty Eagle" Vesterbacka, Rovio is going to expand the franchise of "Angry Birds" in a lot of directions such as movie, broadcast and TV."We are working on a game that will involve Facebook ... really the plan is to make "Angry Birds" playable everywhere," said Vesterbacka. Besides its efforts in digital realm, Rivio is also exploring the potential toy market. Ravio has already sold over two million "Angry Birds" plush toys, which have broken into the mainstream retail channels. Recently Ravio has also branched out into selling "Angry Bird" apparel."Angry Birds", hatched in 2009, has dominated Apple's list of top-selling iPhone apps since it took flight last year. It is now available on many other platforms -- iPad, Android, iTouch, and almost every other smartphone out there.The game became world-polupar as it is easy to pick up and very addictive. Rovio, a mobile game development studio founded in Finland in 2003, enjoys the reputation as one of the most innovative game shops in Europe.

BRUSSELS, April 29 (Xinhua) -- As a 2004 European Union (EU) directive on herbal medicine is to be fully implemented on May 1, herbal medicinal products without a license will no longer be allowed in the EU market, the European Commission said in a press release Friday.The Traditional Herbal Medicinal Products Directive, adopted by the EU member states in 2004, introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to obtain a medicine license.As the transition period is to expire on Saturday, herbal medicinal products from home and abroad, most of which have been sold as food supplements for decades, need to be medically registered or authorized by EU governments in order to remain in the market after May 1.Instead of going through safety tests and clinical trials as regular chemical drugs, applicants are required by the directive to provide documents showing the herbal medicinal product is not harmful in the specified condition of use, as well as evidence that the product at least has a 30-year history of safe use, including 15 years in the EU.However, a wide range of eligibility and technical challenges along with prohibitive costs have so far prevented both local and outside herbal medicinal products from being granted the license.Only a small proportion of indigenous herbal medicinal products have been approved for registration while not a single Chinese or Indian traditional herbal medicinal products have been licensed.Lack of pan-European rules, EU member states had adopted different approaches to herbal medicine, thus creating a "state of anarchy" in the markets despite the fact that indigenous herbs had a 700-year history of use in Europe.Although the directive was intended to harmonize rules of member states and build a level-playing field across the EU, critics argued that the directive may fall short of the aim and create more chaos and uncertainties for the industry.DRAWBACKSThe directive has been under attack for being neither "adequate " nor "appropriate" due to its high registration cost for a single product and its lack of consideration about the Chinese and Indian traditional herbal medicine.Chris Dhaenens, a licensed herbalist in Belgium and a shareholder of a medium-sized herbal importing company doing business with China and ten European countries, said the directive was only appropriate for companies carrying a few products and who could afford the registration costs."It is simply inaccessible to most players distributing high- quality Chinese or Indian herbal products in Europe," he said, adding that the registration fee for a single product could be as high as 150,000 euros.The Alliance for Natural Health, a British-based group representing herbal practitioners, estimated the cost of obtaining a license at between 80,000 and 120,000 pounds (90,000 to 135,000 U.S. dollars) per herb.Dhaenens, who is also the president of the European Benefyt Foundation, a leading traditional medicine group in Europe, argued that the directive only tried to regulate herbal products instead of its practitioners and the whole herbal system, as well as fell short to take the Chinese and Indian traditional medicine into full consideration.Even the European Commission had admitted that the directive was not fit for the registration of Chinese and Indian medicine in an earlier exchange with the European Medicine Agency in Dec. 2008, Dhaenens revealed in an exclusive interview with Xinhua."But they had no money or time to work out an alternative, and so it was left to the member states," he said.

WASHINGTON, April 29 (Xinhua) -- A U.S. appeals court ruled on Friday that the Obama administration can continue the taxpayer- funding for human embryonic stem cell research.The U.S. Court of Appeals in Washington overturned a preliminary federal court order that would have blocked the U.S. Health and Human Services Department and the National Institutes of Health (NIH) from spending government money on embryonic stem cells research."Today's ruling is a victory for our scientists and patients around the world who stand to benefit from the groundbreaking medical research they're pursuing," said Nicholas Papas, a White House spokesman.U.S. President Barack Obama has been trying to expand government funding for human embryonic stem cells research, saying that years of progress on finding cures for spinal cord injuries, Parkinson's disease and other diseases would be lost without the government support on this field.Opponents have been arguing the research is unacceptable because embryonic stem cells can only be obtained through destroying human embryos.Last August, a federal judge ruled that the government-backed embryonic stem cell research violated the law because embryos were destroyed in the process and it jeopardized the position of researchers using adult stem cells for winning federal grants.The government immediately appealed to the ruling, and the appeals court said the research could continue at the NIH before the judge ruled on the case.

HARARE, Feb. 9 (Xinhua) -- The two-day visit to Zimbabwe by Chinese Foreign Minister Yang Jiechi starting Thursday is an endorsement of relations between the Southern African country and China, local figures told Xinhua.Former Zimbabwean ambassador to China Chris Mutsvangwa said in an interview on Tuesday that Yang's visit will also boost economic relations between the two countries."The visit of a foreign minister is a big banner announcement to say that relations between Zimbabwe and China are reaching for a new level," he said."This is a visit which will mark a new diplomatic high watermark in Zimbabwe's international relations because to get the visit of an important and emerging super-power like China with such economic clout is a big vote of confidence on the part of Zimbabweans who have been pummeled by sanctions" imposed by the West.Yang, who will make the visit at the invitation of Zimbabwean Foreign Minister Simbarashe Mumbengegwi, is scheduled to meet President Robert Mugabe and other senior government officials.Mutsvangwa said the Chinese veto at the United Nations in 2008 was "a landmark diplomatic decision where it basically saved Zimbabwe from punitive sanctions instigated by an irate and sulky former colonial power.""So, now this visit will give an opportunity for Zimbabweans tofinally thank China for this act. But more important, cooperation in the economic field is beginning to gather pace because we have crossed the diplomatic and political travails which have been going on in the last 10 years and come out more united because the Chinese veto also enabled Zimbabweans to find accommodation among themselves and led to the GNU and GPA," Mutsvangwa said.China, together with Russia, vetoed the British initiative for full-scale UN sanctions against Zimbabwe, saying the Southern African Development Community (SADC) and the African Union (AU) should be given a chance to resolve the country's political problems.A SADC-driven initiative led to a Government of National Unity (GNU) following the signing of the Global Political Agreement (GPA) between Mugabe and then rivals Prime Minister Morgan Tsvangirai and Deputy Prime Minister Arthur Mutambara."So there is more national unity now among Zimbabweans. It is an opportune moment for us to tighten our relations with China so that we can explore cooperation in the more rewarding material areas of agriculture, mining, tourism and industrialization."There is clearly a lot of scope for cooperation between Zimbabwe and China so that Zimbabwe can quicken its modernization pace taking advantage of the stellar achievements of the Chinese in the above areas," Mutsvangwa said.He cited areas such as telecommunications, international logistics and the internet as being led by the Chinese.China Tobacco has also been on the fore-front reviving tobacco farming in Zimbabwe for the past five years.Mutsvangwa said shortages in the global cotton sector could spur better trade relations between the two countries and lead to more opportunities for Zimbabwean farmers.

BEIJING, April 12 (Xinhuanet) -- The elderly have a difficult time with multi-tasking as a study suggests that older brains behave differently when it comes to switching between two tasks, according to media reports on Tuesday.Researchers used functional magnetic resonance imaging (FMRI) to analyze brain activity in 20 people over age 60 by asking them to contemplate outdoor photos shown briefly. Then the elderly were presented with the picture of a face and asked to determine its gender and age, before being asked to recall details from the original scene they viewed.Researchers then compared their results to a similar experiment with 20 younger adults and found the brains of older subjects were less capable of disengaging from the interruption and reestablishing the neural connections necessary to switch back to focusing on the original memory."Unlike younger individuals, older adults failed to both disengage from the interruption and re-establish functional connections associated with the disrupted memory network," write Wesley C. Clapp of the University of California, San Francisco, and colleagues in the Proceedings of the National Academy of Sciences.The study, published in the online edition of the journal Proceedings of the National Academy of Sciences, sheds new lights into a growing body of studies showing that one's ability to move from one task to another in quick succession becomes more difficult with age.

来源：资阳报